breast cancer and glp 1 drugs misinformation is everywhere—but the research tells a different story. From IVF GLP-1 medications to full-body scans and double mastectomies, BCRF-funded researchers are separating fact from fiction with evidence-based answers A new Penn Medicine study
Pay in 4 interest-free payments of $5.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Live Spec
A new Penn Medicine study of more than 110,000 women found that those who took GLP 1 medications were about 30% less likely to develop breast cancer than those who did not. Presented GLP 1 Receptor Agonists Show a Striking Signal in Breast Cancer Outcomes, but Big Questions Remain OncoDaily Popular weight loss, diabetes drugs linked to improved breast cancer survival VCU Massey Comprehensive Cancer Center GLP 1 use linked to lower breast cancer incidence Penn Medicine Ozempic and similar weight loss drugs linked to 30% lower breast cancer risk ScienceDaily For years, researchers have known that obesity is associated with an increased risk of developing and dying from several cancers, including breast cancer. At ASCO 2026, new studies examining GLP 1 receptor agonists
Store: armz-ageddon.com · Domain: armz-ageddon.com















:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)









